# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- Press Conference
- Reuters
HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target fr...
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.34...
Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company with a unique, ...
HC Wainwright & Co. analyst Yi Chen reiterates Co-Diagnostics (NASDAQ:CODX) with a Neutral and maintains $2 price target.